Navigation Links
Ondine Biopharma Announces Second Quarter 2008 Financial Results
Date:8/14/2008

holly-owned subsidiary of University College London. Periowave(TM) is currently approved in Canada and the European Union for several oral indications. Additional information about Periowave(TM) is available at http://www.periowave.com

About Ondine Biopharma Corporation

Ondine is developing non-antibiotic therapies for the treatment of a broad spectrum of bacterial, fungal and viral infections. The Company is focused on developing and commercializing leading edge products utilizing its patented light-activated technology. Photodisinfection provides broad-spectrum antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance. The Company is based in Vancouver, British Columbia, Canada, with a research and development laboratory in Bothell, Washington, USA, and an international office in St. Michael, Barbados. For additional information, please visit the Company's website at: http://www.ondinebiopharma.com.

Forward-Looking Statements:

Certain statements contained in this release containing words like "believe", "intend", "may", "expect" and other similar expressions, are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the Company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain and develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key
'/>"/>

SOURCE Ondine Biopharma Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Ondine to Present at Canaccord Adams 28th Annual Global Growth Conference
2. Ondine Announces Publication of Positive Results from Pseudomonas aeruginosa Eradication Study
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
8. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
9. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
10. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
11. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 PathoGenetix, Inc., a commercial-stage ... typing, announced today that it has successfully identified and ... strains obtained from the Centers for Disease Control and ... technology. The findings are detailed in a poster ... Society for Microbiology in Denver on Monday. , The ...
(Date:5/20/2013)... Oven Industries Inc. announces a new ... 5R6-900 benchtop controller has many outstanding user-friendly benefits. Contained ... into the wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... can also be used universally, which allows the user ...
(Date:5/20/2013)... -- Pacific Biomarkers and Clinigene International are set to ... at the 2013 AAPS/ National Biotechnology Conference ... Marina , San Diego, ... speak with company representatives at their collaborative seminar, "Biosimilarity, ... 21 from 1-2 p.m. in the conference,s Spinnaker Room. ...
(Date:5/20/2013)... May 20, 2013 Rhythm announced today the ... RM-131, the company,s novel ghrelin agonist for the treatment ... trial demonstrated that RM-131 significantly accelerates early gastric emptying ... diabetic patients with diabetic gastroparesis. The findings were presented ... Orlando and recently published in ...
Breaking Biology Technology:New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3New Laboratory Temperature Controller by Oven Industries 2Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 2Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 3
... Genetics, Inc., a privately held oncology molecular diagnostics company, ... the company,s President, Chief Executive Officer, and newest member ... Metamark co-founder who previously served as interim CEO, will ... Directors. Mr. Straley brings twenty five years ...
... Mass., Nov. 5, 2010 Tomophase Corporation, a leading ... imaging devices, announced that it has received an award ... Human Services for the Qualifying Therapeutic Discovery Project (QTDP.) ... a federally sponsored program that is targeted to projects ...
... Reports Third Quarter Financial Results ... ... --> ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
Cached Biology Technology:Metamark Genetics, Inc. Announces New Chief Executive Officer 2Tomophase Receives Qualifying Therapeutic Discovery Project (QTDP) Award 2OncoGenex Reports Third Quarter Financial Results 2OncoGenex Reports Third Quarter Financial Results 3OncoGenex Reports Third Quarter Financial Results 4OncoGenex Reports Third Quarter Financial Results 5OncoGenex Reports Third Quarter Financial Results 6OncoGenex Reports Third Quarter Financial Results 7OncoGenex Reports Third Quarter Financial Results 8OncoGenex Reports Third Quarter Financial Results 9OncoGenex Reports Third Quarter Financial Results 10OncoGenex Reports Third Quarter Financial Results 11OncoGenex Reports Third Quarter Financial Results 12OncoGenex Reports Third Quarter Financial Results 13
(Date:5/19/2013)... of electricity-producing bacteria that can grow using hydrogen gas ... its sole source of carbon. Researchers at the ... 113th General Meeting of the American Society for Microbiology. ... solely on hydrogen," says Amit Kumar, a researcher on ... of the Lovley Lab Group at the university. , ...
(Date:5/18/2013)... Orlando, FL (May 18, 2013) Research presented today ... liver disease research, with findings about the impact of ... patients. , While coffee consumption recently has been ... found that even a few more cups of java ... particular autoimmune liver disease. Researchers at the Mayo Clinic, ...
(Date:5/17/2013)... 2013) The AGA Research Foundation announced a new ... between the gut microbiota, one of today,s most exciting ... , The AGA Research Awards Panel selected Andrew T. ... Hospital and Harvard Medical School, Boston, as the 2013 ... will receive $25,000 of funding, commencing in July 2013, ...
Breaking Biology News(10 mins):Coffee consumption associated with reduced risk of autoimmune liver disease 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
... May 7, 2012 - A new innovation can completely reshape ... of genetically engineered (GE) crops in the 1980,s ignited a ... crop yields and better nutritional content, along with the reduction ... play a significant role in the U.S., with more than ...
... research long-term is to develop more efficient biofuel cells, seen ... by readily available biological materials, they have the potential to ... is it not possible to replace a battery or recharge ... process glucose, but the Leeds research will focus on bacterial ...
... in more than 200 outlet glaciers indicates that Greenland,s contribution ... significantly less than the upper limits some scientists thought possible. ... National Science Foundation (NSF) and NASA and published in today,s ... a melting Greenland,s contributions to rising sea levels could be ...
Cached Biology News:New research reveals challenges in genetically engineered crop regulatory process 2New research reveals challenges in genetically engineered crop regulatory process 3Creating energy from light and air - new research on biofuel cells 2Analysis of speed of Greenland glaciers gives new insight for rising sea level 2Analysis of speed of Greenland glaciers gives new insight for rising sea level 3
Request Info...
PGC-1 (H-300)...
Mouse VEGF R1/Flt-1 Allophycocyanin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Mouse Anti-Amyloid beta [1-16], clone 6E10, Monoclonal Antibody...
Biology Products: